ETF seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses

Khiron Life Sciences Corp. has been added to the Horizons Marijuana Life Sciences Index ETF, marking the company’s elevation to the senior index of publicly traded North American companies with significant business activity in the cannabis industry.

HMMJ is an index ETF that “seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses,” reports Khiron Life Sciences, an integrated medical cannabis company with its core operations in Colombia.

“This index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry,” notes the company statement.

The index “selects from a current universe of companies that have operations that may include one or more of biopharmaceuticals, medical manufacturing, distribution, bio-products and other ancillary businesses related to the marijuana industry,” it adds.

With core operations in Colombia, Khiron Life Sciences is fully licensed in the country for the cultivation, production, domestic distribution and international export of both THC and CBD medical cannabis.

Want to keep up to date on what’s happening in the world of cannabis? Subscribe to the Cannabis Post newsletter for weekly insights into the industry, what insiders will be talking about and content from across the Postmedia Network.